首页|枳术宽中胶囊联合莫沙必利对脾虚气滞型功能性消化不良患者胃肠激素、胃排空情况的影响

枳术宽中胶囊联合莫沙必利对脾虚气滞型功能性消化不良患者胃肠激素、胃排空情况的影响

扫码查看
目的 探究枳术宽中胶囊联合莫沙必利对脾虚气滞型功能性消化不良(FD)患者胃肠激素、胃排空情况的影响。方法 选择 2019 年12 月至2022年 3 月我院收治的102 例脾虚气滞型FD患者为研究对象,按照随机数字表法将其分为对照组和观察组,各 51 例。对照组口服莫沙必利,观察组在对照组治疗基础上加服枳术宽中胶囊,均持续治疗 1 个月。比较两组的临床疗效、胃肠激素、胃排空情况及不良反应发生情况。结果 观察组的治疗总有效率高于对照组(P<0。05)。治疗后,两组的促胃泌素(GAS)、血管活性肽(VIP)、胆囊收缩素(CCK)水平低于治疗前,胃动素(MTL)水平高于治疗前,且观察组优于对照组(P<0。05)。治疗后,两组的胃排空率高于治疗前,且观察组高于对照组(P<0。05)。两组的不良反应总发生率比较,差异无统计学意义(P=0。402)。结论 枳术宽中胶囊联合莫沙必利治疗脾虚气滞型FD患者效果显著,能够有效调节胃肠激素水平,加快胃排空,安全可靠,可于临床推广。
Effects of Zhizhu Kuanzhong capsules combined with mosapride on gastrointestinal hormones and gastric emptying in patients with functional dyspepsia of spleen deficiency and Qi stagnation
Objective To explore the effects of Zhizhu Kuanzhong capsules combined with mosapride on gastrointestinal hormones and gastric emptying in patients with functional dyspepsia(FD)of spleen deficiency and Qi stagnation.Methods A total of 102 FD patients with spleen deficiency and Qi stagnation admitted in our hospital from December 2019 to March 2022 were selected as the research objects,the patients were divided into control group and observation group according to the random number table method,with 51 cases in each group.The control group was treated with mosapride orally,and the observation group was treated with Zhizhu Kuanzhong capsules on the basis of the control group,both of groups were treated for 1 month.The clinical efficacy,gastrointestinal hormones,gastric emptying and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was higher than that in the control group(P<0.05).After treatment,the levels of gastrin(GAS),vasoactive intestinal peptide(VIP)and cholecystokinin(CCK)in the two groups were lower than those before treatment,and the level of motilin(MTL)was higher than that before treatment,and those in the observation group were better than the control group(P<0.05).After treatment,the gastric emptying rate of the two groups was higher than that before treatment,and that of the observation group was higher than the control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P=0.402).Conclusion Zhizhu Kuanzhong capsules combined with mosapride has a significant effect in the treatment of FD patients with spleen deficiency and Qi stagnation.It can effectively regulate the levels of gastrointestinal hormones and accelerate gastric emptying,which is safe and reliable,and can be promoted in clinical practice.

functional dyspepsiaspleen deficiency and Qi stagnationZhizhu Kuanzhong capsulemosapridegastrointestinal hormonegastric emptying

刘芳芳、王捷虹、许永攀、穆恒、杨燕燕

展开 >

陕西中医药大学附属医院消化一科,陕西 咸阳,712000

功能性消化不良 脾虚气滞 枳术宽中胶囊 莫沙必利 胃肠激素 胃排空

陕西中医药大学附属医院科研项目

2020XZ001

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(9)
  • 19